ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS)
CNY 10.84
(0.18%)
CNY 10.84
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 443.11 Million | 733.47 Million | 485.57 Million | 542.37 Million | 155.49 Million | 383.46 Million |
| Net Income | 395.01 Million | 388.26 Million | 374.73 Million | 360.2 Million | 352.09 Million | 302.55 Million |
| Depreciation & Amortization | 103.65 Million | 95.6 Million | 85.93 Million | 60.88 Million | 61.07 Million | 61.81 Million |
| Deferred income taxes | -2.77 Million | -3.56 Million | 2.7 Million | 1.38 Million | -910.05 Thousand | 2.54 Million |
| Stock-based compensation | 10.59 Million | 12.83 Million | - | - | - | - |
| Change in working capital | -81.66 Million | 246.92 Million | 65.76 Million | 129.47 Million | -233.01 Million | 29.29 Million |
| Other non-cash items | 26.11 Million | 2.68 Million | -40.86 Million | -8.19 Million | -24.66 Million | -10.19 Million |
| Investing Cash Flow | 585.28 Million | 122.14 Million | -43.34 Million | -961.54 Million | 176.29 Million | 275 Million |
| Investments in PPE | -43.98 Million | -34.43 Million | -71.88 Million | -97.23 Million | -40.61 Million | -46.39 Million |
| Acquisitions | 0.76 | 196.4 Thousand | 30.82 Million | 103.64 Million | 72.97 Million | - |
| Investment purchases | -402 Million | -2.1 Billion | -1.57 Billion | -2.64 Billion | -284.96 Million | -903.98 Million |
| Sales/Maturities of investments | 1.03 Billion | 2.25 Billion | 1.56 Billion | 1.77 Billion | 469.51 Million | 1.22 Billion |
| Other Investing Activities | 56.28 Thousand | -0.76 | 0.89 | -97.23 Million | -40.61 Million | 2.48 Million |
| Financing Cash Flow | -202 Million | -264.18 Million | -520.57 Million | -104.23 Million | -180.72 Million | -124.72 Million |
| Debt repayment | -50.72 Million | -15 Million | -127.56 Million | -19.11 Million | -6.2 Million | -10.6 Million |
| Dividends payments | -149.53 Million | -257.88 Million | -418.5 Million | -209.25 Million | -167.4 Million | -104.98 Million |
| Common Stock Repurchased | -3.38 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.06 Million | -539.35 Thousand | 36.51 Million | 124.22 Million | -7.38 Million | -9.13 Million |
| Accounts receivables | -8.68 Million | -163.71 Million | 275.85 Million | 27.17 Million | -362.1 Million | 84.44 Million |
| Accounts payables | -132.49 Million | 465.42 Million | -160.39 Million | 128.16 Million | 159.13 Million | 6.97 Million |
| Inventory | 62.28 Million | -51.21 Million | -52.39 Million | -27.25 Million | -29.13 Million | -64.67 Million |
| Other working capital | -2.77 Million | -3.56 Million | 2.7 Million | 1.38 Million | -910.05 Thousand | 93.96 Million |
| Cash at beginning of period | 1.1 Billion | 510.5 Million | 588.84 Million | 1.11 Billion | 961.19 Million | 427.44 Million |
| Cash at end of period | 1.92 Billion | 1.1 Billion | 510.5 Million | 588.84 Million | 1.11 Billion | 961.19 Million |
| Capital Expenditure | -43.98 Million | -34.43 Million | -71.88 Million | -97.23 Million | -40.61 Million | -46.39 Million |
| Effect of forex changes on cash | 1.33 | 1.52 | 0.95 | 0.58 | 0.09 | - |
| Net cash flow / Change in cash | 826.39 Million | 591.43 Million | -78.34 Million | -523.41 Million | 151.06 Million | 533.74 Million |
| Free Cash Flow | 399.12 Million | 699.03 Million | 413.69 Million | 445.13 Million | 114.88 Million | 337.07 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 50.35 Million | 71.52 Million | 46.19 Million | 395.01 Million | 79.41 Million | 80.19 Million |
| Depreciation & Amortization | - | 31.42 Million | 31.42 Million | 103.65 Million | 32.78 Million | -47.02 Million |
| Deferred income taxes | - | - | - | -2.77 Million | -64.19 Million | -53.11 Million |
| Stock-based compensation | - | 1.48 Million | - | 10.59 Million | 10.59 Million | -7.59 Million |
| Change in working capital | - | -137 Million | - | -81.66 Million | 53.6 Million | 107.72 Million |
| Other non-cash items | 81.82 Million | 52.77 Million | -216.4 Million | 26.11 Million | 256.88 Million | 90.27 Million |
| Investing Cash Flow | -12.48 Million | -4.89 Million | -10.38 Million | 585.28 Million | -6.28 Million | 190.3 Million |
| Investments in PPE | -18.11 Million | -5 Million | -10.38 Million | -43.98 Million | -6.28 Million | 7.93 Million |
| Acquisitions | - | - | - | 0.76 | - | 56.28 Thousand |
| Investment purchases | -1.06 Million | - | - | -402 Million | -50 Million | -56.28 Thousand |
| Sales/Maturities of investments | 6.69 Million | - | - | 1.03 Billion | 50 Million | 182.3 Million |
| Other Investing Activities | -1.06 Million | 117 Thousand | - | 56.28 Thousand | - | 56.28 Thousand |
| Financing Cash Flow | -35.73 Million | -173.16 Million | -17.49 Million | -202 Million | -8.12 Million | -52.05 Million |
| Debt repayment | -31.74 Million | - | - | -50.72 Million | -2.2 Million | - |
| Dividends payments | -3.99 Million | -150.91 Million | -957.68 Thousand | -149.53 Million | -560.5 Thousand | -50.08 Million |
| Common Stock Repurchased | 16.53 Million | -16.53 Million | - | -3.38 Million | -3.38 Million | 1.4 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -154.42 Million | -16.53 Million | -13.06 Million | -10.11 Million | -3.38 Million |
| Accounts receivables | - | -123.3 Million | - | -8.68 Million | -8.68 Million | 125.88 Million |
| Accounts payables | - | - | - | -132.49 Million | - | - |
| Inventory | - | -13.7 Million | - | 62.28 Million | 62.28 Million | -18.15 Million |
| Other working capital | - | - | - | -2.77 Million | - | - |
| Cash at beginning of period | 1.64 Billion | 1.73 Billion | 1.92 Billion | 1.1 Billion | 1.57 Billion | 1.26 Billion |
| Cash at end of period | 1.72 Billion | 1.64 Billion | 1.73 Billion | 1.92 Billion | 1.92 Billion | 1.57 Billion |
| Capital Expenditure | -18.11 Million | -5 Million | -10.38 Million | -43.98 Million | -6.28 Million | 7.93 Million |
| Effect of forex changes on cash | - | - | - | 1.33 | 0.44 | -343.74 Thousand |
| Net cash flow / Change in cash | 78.33 Million | -85.29 Million | -198.08 Million | 826.39 Million | 354.67 Million | 308.37 Million |
| Free Cash Flow | 114.07 Million | 87.86 Million | -180.59 Million | 399.12 Million | 362.79 Million | 178.41 Million |
EKTER
KNTK
ALFREDHE
XPLRA
APLP
EBR